Clin2
NCT06822946Possibly a fitRecruiting

Zhibitai Capsules for High Cholesterol

Primary Hyperlipidemia

Part of Heart & circulation, Hormones & metabolism clinical trials.

This trial tests if Zhibitai Capsules can lower high cholesterol in people with primary hyperlipidemia (high fat levels in the blood). It may be a treatment option for those who cannot take standard medications.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
192 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old.
  • Your body mass index (BMI) is between 18 and 30.
  • You have high LDL (bad) cholesterol (at least 3.4 mmol/L) and your triglycerides (another type of fat) are not too high (4.5 mmol/L or less).
  • You have not taken any cholesterol-lowering medications (like statins) or certain weight-loss drugs for at least 4 weeks before starting.
  • You are willing to follow a stable diet and exercise plan, take the study medication, and fill out diary cards.
  • You do not have severe heart, liver, kidney, or muscle disease, and you are not pregnant or planning pregnancy.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07444086Not yet recruiting· Phase 3
A study of a new medicine for high cholesterol

This trial tests if a new drug, QLC7401, can lower cholesterol in people with high cholesterol who are not on other cholesterol medicines. It may be an option if you have low or medium risk of heart disease and no history of heart problems.

NCT07441317Not yet recruiting· Phase 3
Testing a new drug for stubborn high cholesterol

This trial tests a new medication (QLC7401) for people with high cholesterol that is not well controlled by their current treatment. It aims to see if the drug can help lower LDL-C (bad cholesterol) levels and reduce the risk of heart problems.

NCT07421284Not yet recruiting· Phase 3
Study of SYH2053 for high cholesterol in Chinese adults

This trial tests a new investigational medicine (SYH2053) for people with high cholesterol or mixed hyperlipidemia who are already on cholesterol-lowering therapy but still have high levels of 'bad cholesterol' (LDL-C). The goal is to see if this add-on treatment can help lower cholesterol further and reduce heart disease risk.

Beijing, Beijing Municipality
NCT06700408Not yet recruiting· Phase 2
Chinese medicine for high cholesterol

This trial tests whether a Chinese medicine treatment can lower high cholesterol. You may qualify if you have very high LDL cholesterol and are not currently on statins.

NCT07610278Recruiting· Phase 2
Blood Pressure and Cholesterol Treatment Study

This study tests a combination of two new medications (QCZ484 and inclisiran) designed to lower both blood pressure and cholesterol levels. You may be a good fit if you have high blood pressure and high cholesterol that isn't fully controlled by current treatments.

Foley, Alabama
NCT06750341Not yet recruiting· Phase 2
Study of QLC7401 for high cholesterol

This trial tests an experimental drug, QLC7401, for people with high LDL cholesterol that hasn't lowered enough with current treatments. It aims to see if the drug can help reduce cholesterol levels in patients who are already on stable cholesterol medication.

Hear when a new Primary Hyperlipidemia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.